Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultragenyx Pharmaceutical (RARE) Change in Inventory: 2017-2024

Historic Change in Inventory for Ultragenyx Pharmaceutical (RARE) over the last 8 years, with Dec 2024 value amounting to $11.2 million.

  • Ultragenyx Pharmaceutical's Change in Inventory rose 123.80% to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.6 million, marking a year-over-year decrease of 19.62%. This contributed to the annual value of $11.2 million for FY2024, which is 61.72% up from last year.
  • Ultragenyx Pharmaceutical's Change in Inventory amounted to $11.2 million in FY2024, which was up 61.72% from $6.9 million recorded in FY2023.
  • Over the past 5 years, Ultragenyx Pharmaceutical's Change in Inventory peaked at $11.2 million during FY2024, and registered a low of $1.3 million during FY2020.
  • In the last 3 years, Ultragenyx Pharmaceutical's Change in Inventory had a median value of $9.7 million in 2022 and averaged $9.3 million.
  • As far as peak fluctuations go, Ultragenyx Pharmaceutical's Change in Inventory plummeted by 69.76% in 2020, and later spiked by 211.23% in 2022.
  • Ultragenyx Pharmaceutical's Change in Inventory (Yearly) stood at $1.3 million in 2020, then surged by 131.58% to $3.1 million in 2021, then skyrocketed by 211.23% to $9.7 million in 2022, then decreased by 28.56% to $6.9 million in 2023, then skyrocketed by 61.72% to $11.2 million in 2024.